- Home
- AVDL vs ARHS Comparison
AVDL vs ARHS Comparison
Compare AVDL & ARHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVDL
- ARHS
- Stock Information
- Founded
- AVDL 2015
- ARHS 1986
- Country
- AVDL Ireland
- ARHS United States
- Employees
- AVDL N/A
- ARHS N/A
- Industry
- AVDL Biotechnology: Pharmaceutical Preparations
- ARHS Other Specialty Stores
- Sector
- AVDL Health Care
- ARHS Consumer Discretionary
- Exchange
- AVDL Nasdaq
- ARHS Nasdaq
- Market Cap
- AVDL 1.4B
- ARHS 1.3B
- IPO Year
- AVDL 1996
- ARHS 2021
- Fundamental
- Price
- AVDL $14.54
- ARHS $11.73
- Analyst Decision
- AVDL Strong Buy
- ARHS Buy
- Analyst Count
- AVDL 7
- ARHS 13
- Target Price
- AVDL $19.86
- ARHS $11.71
- AVG Volume (30 Days)
- AVDL 1.4M
- ARHS 2.4M
- Earning Date
- AVDL 08-07-2025
- ARHS 08-07-2025
- Dividend Yield
- AVDL N/A
- ARHS N/A
- EPS Growth
- AVDL N/A
- ARHS N/A
- EPS
- AVDL N/A
- ARHS 0.50
- Revenue
- AVDL $221,075,000.00
- ARHS $1,335,951,000.00
- Revenue This Year
- AVDL $63.77
- ARHS $8.41
- Revenue Next Year
- AVDL $29.91
- ARHS $7.04
- P/E Ratio
- AVDL N/A
- ARHS $23.46
- Revenue Growth
- AVDL 132.35
- ARHS 4.76
- 52 Week Low
- AVDL $6.38
- ARHS $6.61
- 52 Week High
- AVDL $16.66
- ARHS $13.97
- Technical
- Relative Strength Index (RSI)
- AVDL 70.53
- ARHS 55.80
- Support Level
- AVDL $14.52
- ARHS $11.54
- Resistance Level
- AVDL $14.99
- ARHS $12.14
- Average True Range (ATR)
- AVDL 0.53
- ARHS 0.48
- MACD
- AVDL -0.00
- ARHS -0.13
- Stochastic Oscillator
- AVDL 63.55
- ARHS 24.29
About AVDL Avadel Pharmaceuticals plc
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.
About ARHS Arhaus Inc.
Arhaus Inc is a growing lifestyle brand and omnichannel retailer of premium home furniture. The company offers merchandise in several categories, including furniture, outdoor, lighting, textiles, and decor through its Retail and e-commerce sales channels.